{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:40:45Z","timestamp":1773700845232,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"BMBF","award":["01GM1904A"],"award-info":[{"award-number":["01GM1904A"]}]},{"name":"NCN","award":["CN82K"],"award-info":[{"award-number":["CN82K"]}]},{"DOI":"10.13039\/100018390","name":"Uniwersytet Szczeci\u0144ski","doi-asserted-by":"publisher","award":["PUM 330-01\/S\/23"],"award-info":[{"award-number":["PUM 330-01\/S\/23"]}],"id":[{"id":"10.13039\/100018390","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s11739-024-03533-7","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T19:01:32Z","timestamp":1710788492000},"page":"1229-1234","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dysbiosis and nutrition in steatotic liver disease: addressing the unrecognized small intestinal bacterial overgrowth (SIBO) challenge"],"prefix":"10.1007","volume":"19","author":[{"given":"Ewa","family":"Stachowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Gudan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Ma\u0144kowska-Wierzbicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Liebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0113-0777","authenticated-orcid":false,"given":"Marcin","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,18]]},"reference":[{"issue":"12","key":"3533_CR1","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","volume":"384","author":"PN Newsome","year":"2021","unstructured":"Newsome PN, Buchholtz K, Cusi K et al (2021) A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis. N Engl J Med 384(12):1113\u20131124. https:\/\/doi.org\/10.1056\/NEJMoa2028395","journal-title":"N Engl J Med"},{"issue":"3","key":"3533_CR2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jhep.2022.04.003","volume":"77","author":"N Alkhouri","year":"2022","unstructured":"Alkhouri N, Herring R, Kabler H et al (2022) Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: a randomised, open-label phase II trial. J Hepatol 77(3):607\u2013618. https:\/\/doi.org\/10.1016\/j.jhep.2022.04.003","journal-title":"J Hepatol"},{"issue":"6","key":"3533_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S2468-1253(23)00068-7","volume":"8","author":"R Loomba","year":"2023","unstructured":"Loomba R, Abdelmalek MF, Armstrong MJ et al (2023) Semaglutide 2.4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial. Lancet Gastroenterol Hepatol 8(6):511\u2013522. https:\/\/doi.org\/10.1016\/S2468-1253(23)00068-7","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"3533_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/TP.0000000000002483","volume":"103","author":"V Ratziu","year":"2019","unstructured":"Ratziu V, Ghabril M, Romero-Gomez M, Svegliati-Baroni G (2019) Recommendations for management and treatment of nonalcoholic steatohepatitis. Transplantation 103(1):28\u201338. https:\/\/doi.org\/10.1097\/TP.0000000000002483","journal-title":"Transplantation"},{"issue":"3","key":"3533_CR5","doi-asserted-by":"publisher","first-page":"13659","DOI":"10.1111\/eci.13659","volume":"52","author":"N Pugliese","year":"2022","unstructured":"Pugliese N, Plaz Torres MC, Petta S, Valenti L, Giannini EG, Aghemo A (2022) Is there an \u2018ideal\u2019 diet for patients with NAFLD? Eur J Clin Invest 52(3):13659. https:\/\/doi.org\/10.1111\/eci.13659","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"3533_CR6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE et al (2018) The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American association for the study of liver diseases. Hepatology 67(1):328\u2013357. https:\/\/doi.org\/10.1002\/hep.29367","journal-title":"Hepatology"},{"issue":"5","key":"3533_CR7","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1002\/hep.26594","volume":"58","author":"T Ishimoto","year":"2013","unstructured":"Ishimoto T, Lanaspa MA, Rivard CJ et al (2013) High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase. Hepatology 58(5):1632\u20131643. https:\/\/doi.org\/10.1002\/hep.26594","journal-title":"Hepatology"},{"issue":"3","key":"3533_CR8","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1053\/j.gastro.2022.06.023","volume":"163","author":"MT Long","year":"2022","unstructured":"Long MT, Noureddin M, Lim JK (2022) AGA Clinical practice update: diagnosis and management of nonalcoholic fatty liver disease in lean individuals: expert review. Gastroenterology 163(3):764\u2013774. https:\/\/doi.org\/10.1053\/j.gastro.2022.06.023","journal-title":"Gastroenterology"},{"key":"3533_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev-nutr-062220-025831","volume":"42","author":"S Jung","year":"2022","unstructured":"Jung S, Bae H, Song WS, Jang C (2022) Dietary fructose and fructose-induced pathologies. Annu Rev Nutr 42:45\u201366. https:\/\/doi.org\/10.1146\/annurev-nutr-062220-025831","journal-title":"Annu Rev Nutr"},{"issue":"5","key":"3533_CR10","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS et al (2023) AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77(5):1797\u20131835. https:\/\/doi.org\/10.1097\/HEP.0000000000000323","journal-title":"Hepatology"},{"issue":"16","key":"3533_CR11","doi-asserted-by":"publisher","first-page":"8968","DOI":"10.1021\/jf201777w","volume":"59","author":"M Tabernero","year":"2011","unstructured":"Tabernero M, Venema K, Maathuis AJ, Saura-Calixto FD (2011) Metabolite production during in vitro colonic fermentation of dietary fiber: analysis and comparison of two European diets. J Agric Food Chem 59(16):8968\u20138975. https:\/\/doi.org\/10.1021\/jf201777w","journal-title":"J Agric Food Chem"},{"issue":"11","key":"3533_CR12","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1136\/gutjnl-2015-309957","volume":"65","author":"F De Filippis","year":"2016","unstructured":"De Filippis F, Pellegrini N, Vannini L et al (2016) High-level adherence to a mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut 65(11):1812\u20131821. https:\/\/doi.org\/10.1136\/gutjnl-2015-309957","journal-title":"Gut"},{"issue":"7961","key":"3533_CR13","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41586-023-05989-7","volume":"617","author":"D Shalon","year":"2023","unstructured":"Shalon D, Culver RN, Grembi JA et al (2023) Profiling the human intestinal environment under physiological conditions. Nature 617(7961):581\u2013591. https:\/\/doi.org\/10.1038\/s41586-023-05989-7","journal-title":"Nature"},{"issue":"5","key":"3533_CR14","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s42255-023-00777-z","volume":"5","author":"J Folz","year":"2023","unstructured":"Folz J, Culver RN, Morales JM et al (2023) Human metabolome variation along the upper intestinal tract. Nat Metab 5(5):777\u2013788. https:\/\/doi.org\/10.1038\/s42255-023-00777-z","journal-title":"Nat Metab"},{"issue":"2","key":"3533_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jceh.2018.08.006","volume":"9","author":"G Ghosh","year":"2019","unstructured":"Ghosh G, Jesudian AB (2019) Small intestinal bacterial overgrowth in patients with cirrhosis. J Clin Exp Hepatol Mar-Apr 9(2):257\u2013267. https:\/\/doi.org\/10.1016\/j.jceh.2018.08.006","journal-title":"J Clin Exp Hepatol Mar-Apr"},{"issue":"5","key":"3533_CR16","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1007\/s10620-010-1447-3","volume":"56","author":"AA Shanab","year":"2011","unstructured":"Shanab AA, Scully P, Crosbie O et al (2011) Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8. Dig Dis Sci 56(5):1524\u20131534. https:\/\/doi.org\/10.1007\/s10620-010-1447-3","journal-title":"Dig Dis Sci"},{"issue":"3","key":"3533_CR17","first-page":"143","volume":"52","author":"IG Moraru","year":"2014","unstructured":"Moraru IG, Moraru AG, Andrei M et al (2014) Small intestinal bacterial overgrowth is associated to symptoms in irritable bowel syndrome. evidence from a multicentre study in Romania. Rom J Intern Med 52(3):143\u2013150","journal-title":"Rom J Intern Med"},{"issue":"2","key":"3533_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1136\/flgastro-2022-102163","volume":"14","author":"JF Ahmed","year":"2023","unstructured":"Ahmed JF, Padam P, Ruban A (2023) Aetiology, diagnosis and management of small intestinal bacterial overgrowth. Frontline Gastroenterol 14(2):149\u2013154. https:\/\/doi.org\/10.1136\/flgastro-2022-102163","journal-title":"Frontline Gastroenterol"},{"issue":"5","key":"3533_CR19","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s12664-022-01292-x","volume":"41","author":"UC Ghoshal","year":"2022","unstructured":"Ghoshal UC, Sachdeva S, Ghoshal U et al (2022) Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: an initiative of the Indian neurogastroenterology and motility association. Indian J Gastroenterol 41(5):483\u2013507. https:\/\/doi.org\/10.1007\/s12664-022-01292-x","journal-title":"Indian J Gastroenterol"},{"issue":"7","key":"3533_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13768","volume":"52","author":"A Di Ciaula","year":"2022","unstructured":"Di Ciaula A, Bonfrate L, Portincasa P (2022) The role of microbiota in nonalcoholic fatty liver disease. Eur J Clin Invest 52(7):e13768. https:\/\/doi.org\/10.1111\/eci.13768","journal-title":"Eur J Clin Invest"},{"issue":"14","key":"3533_CR21","doi-asserted-by":"publisher","first-page":"7702","DOI":"10.3390\/ijms22147702","volume":"22","author":"A Di Ciaula","year":"2021","unstructured":"Di Ciaula A, Calamita G, Shanmugam H et al (2021) Mitochondria matter: systemic aspects of nonalcoholic fatty liver disease (NAFLD) and diagnostic assessment of liver function by stable isotope dynamic breath tests. Int J Mol Sci 22(14):7702. https:\/\/doi.org\/10.3390\/ijms22147702","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3533_CR22","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/hep.22848","volume":"49","author":"L Miele","year":"2009","unstructured":"Miele L, Valenza V, La Torre G et al (2009) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 49(6):1877\u20131887. https:\/\/doi.org\/10.1002\/hep.22848","journal-title":"Hepatology"},{"issue":"3","key":"3533_CR23","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3390\/microorganisms11030723","volume":"11","author":"P Gkolfakis","year":"2023","unstructured":"Gkolfakis P, Tziatzios G, Leite G et al (2023) Prevalence of small intestinal bacterial overgrowth syndrome in patients with non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: a cross-sectional study. Microorganisms. 11(3):723. https:\/\/doi.org\/10.3390\/microorganisms11030723","journal-title":"Microorganisms."},{"key":"3533_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.872428","volume":"9","author":"E Scarpellini","year":"2022","unstructured":"Scarpellini E, Abenavoli L, Cassano V et al (2022) The apparent asymmetrical relationship between small bowel bacterial overgrowth, endotoxemia, and liver steatosis and fibrosis in cirrhotic and non-cirrhotic patients: a single-center pilot study. Front Med (Lausanne) 9:872428. https:\/\/doi.org\/10.3389\/fmed.2022.872428","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"3533_CR25","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/MEG.0000000000001541","volume":"32","author":"K Wijarnpreecha","year":"2020","unstructured":"Wijarnpreecha K, Lou S, Watthanasuntorn K et al (2020) Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 32(5):601\u2013608. https:\/\/doi.org\/10.1097\/MEG.0000000000001541","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"24","key":"3533_CR26","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.3390\/nu14245261","volume":"14","author":"A Gudan","year":"2022","unstructured":"Gudan A, Jamiol-Milc D, Hawrylkowicz V, Skonieczna-Zydecka K, Stachowska E (2022) The prevalence of small intestinal bacterial overgrowth in patients with non-alcoholic liver diseases: NAFLD, NASH, fibrosis, cirrhosis-a systematic review, meta-analysis and meta-regression. Nutrients 14(24):5261. https:\/\/doi.org\/10.3390\/nu14245261","journal-title":"Nutrients"},{"issue":"5","key":"3533_CR27","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","volume":"156","author":"L Castera","year":"2019","unstructured":"Castera L, Friedrich-Rust M, Loomba R (2019) Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology 156(5):1264\u20131281. https:\/\/doi.org\/10.1053\/j.gastro.2018.12.036","journal-title":"Gastroenterology"},{"issue":"4","key":"3533_CR28","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00125-011-2446-4","volume":"55","author":"G Musso","year":"2012","unstructured":"Musso G, Cassader M, Rosina F, Gambino R (2012) Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia 55(4):885\u2013904. https:\/\/doi.org\/10.1007\/s00125-011-2446-4","journal-title":"Diabetologia"},{"issue":"1","key":"3533_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1053\/j.gastro.2013.09.046","volume":"146","author":"EP Halmos","year":"2014","unstructured":"Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG (2014) A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 146(1):67\u201375. https:\/\/doi.org\/10.1053\/j.gastro.2013.09.046","journal-title":"Gastroenterology"},{"issue":"3","key":"3533_CR30","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/1751-2980.13189","volume":"24","author":"KH Chuah","year":"2023","unstructured":"Chuah KH, Hian WX, Lim SZ, Beh KH, Mahadeva S (2023) Impact of small intestinal bacterial overgrowth on symptoms and quality of life in irritable bowel syndrome. J Dig Dis 24(3):194\u2013202. https:\/\/doi.org\/10.1111\/1751-2980.13189","journal-title":"J Dig Dis"},{"issue":"4","key":"3533_CR31","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1053\/j.gastro.2020.06.090","volume":"159","author":"EMM Quigley","year":"2020","unstructured":"Quigley EMM, Murray JA, Pimentel M (2020) AGA clinical practice update on small intestinal bacterial overgrowth: expert review. Gastroenterology 159(4):1526\u20131532. https:\/\/doi.org\/10.1053\/j.gastro.2020.06.090","journal-title":"Gastroenterology"},{"issue":"2","key":"3533_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/jhn.12530","volume":"31","author":"K Whelan","year":"2018","unstructured":"Whelan K, Martin LD, Staudacher HM, Lomer MCE (2018) The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice. J Hum Nutr Diet 31(2):239\u2013255. https:\/\/doi.org\/10.1111\/jhn.12530","journal-title":"J Hum Nutr Diet"},{"issue":"3","key":"3533_CR33","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1017\/S0029665116000021","volume":"75","author":"HM Staudacher","year":"2016","unstructured":"Staudacher HM, Whelan K (2016) Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet. Proc Nutr Soc 75(3):306\u2013318. https:\/\/doi.org\/10.1017\/S0029665116000021","journal-title":"Proc Nutr Soc"},{"issue":"3","key":"3533_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/MOG.0000000000000928","volume":"39","author":"A Shah","year":"2023","unstructured":"Shah A, Ghoshal UC, Holtmann GJ (2023) Unravelling the controversy with small intestinal bacterial overgrowth. Curr Opin Gastroenterol 39(3):211\u2013218. https:\/\/doi.org\/10.1097\/MOG.0000000000000928","journal-title":"Curr Opin Gastroenterol"},{"issue":"8","key":"3533_CR35","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.3390\/molecules28083564","volume":"28","author":"O Pitirollo","year":"2023","unstructured":"Pitirollo O, Grimaldi M, Corradini C, Pironi S, Cavazza A (2023) HPAEC-PAD analytical evaluation of carbohydrates pattern for the study of technological parameters effects in low-FODMAP food production. Molecules 28(8):3564. https:\/\/doi.org\/10.3390\/molecules28083564","journal-title":"Molecules"},{"issue":"3","key":"3533_CR36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/0884533613485882","volume":"28","author":"M Bohm","year":"2013","unstructured":"Bohm M, Siwiec RM, Wo JM (2013) Diagnosis and management of small intestinal bacterial overgrowth. Nutr Clin Pract 28(3):289\u2013299. https:\/\/doi.org\/10.1177\/0884533613485882","journal-title":"Nutr Clin Pract"},{"issue":"6","key":"3533_CR37","doi-asserted-by":"publisher","first-page":"e8860","DOI":"10.7759\/cureus.8860","volume":"12","author":"TGO Achufusi","year":"2020","unstructured":"Achufusi TGO, Sharma A, Zamora EA, Manocha D (2020) Small intestinal bacterial overgrowth: comprehensive review of diagnosis, prevention, and treatment methods. Cureus. 12(6):e8860. https:\/\/doi.org\/10.7759\/cureus.8860","journal-title":"Cureus."},{"issue":"2","key":"3533_CR38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/jhn.12706","volume":"33","author":"A Weynants","year":"2020","unstructured":"Weynants A, Goossens L, Genetello M, De Looze D, Van Winckel M (2020) The long-term effect and adherence of a low fermentable oligosaccharides disaccharides monosaccharides and polyols (FODMAP) diet in patients with irritable bowel syndrome. J Hum Nutr Diet 33(2):159\u2013169. https:\/\/doi.org\/10.1111\/jhn.12706","journal-title":"J Hum Nutr Diet"},{"key":"3533_CR39","doi-asserted-by":"publisher","unstructured":"Currenti W, Losavio F, Quiete S et al (2023) Comparative evaluation of a low-carbohydrate diet and a mediterranean diet in overweight\/obese patients with type 2 diabetes mellitus: a 16-week intervention study. Nutrients 16(1):95. https:\/\/doi.org\/10.3390\/nu16010095","DOI":"10.3390\/nu16010095"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-024-03533-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-024-03533-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-024-03533-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T06:12:59Z","timestamp":1724998379000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-024-03533-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["3533"],"URL":"https:\/\/doi.org\/10.1007\/s11739-024-03533-7","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,18]]},"assertion":[{"value":"25 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statements on human and animal rights"}},{"value":"None","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}